NewcelX Ltd. (NCEL)
NCEL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.84
-2.20% on the day
Market cap
$16.4M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | NCEL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Switzerland |
| IPO year | 2021 |
| SEC CIK | 0001783036 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | V8 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1 | POS AM | 2026-09-18 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-29 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-18 |
Source: SEC EDGAR submissions feed, 416 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RADX | Radiopharm Theranostics Limited | $1.20 | +8.10% | $17.3M |
| MRKR | Marker Therapeutics Inc. | $0.9249 | -8.43% | $15.4M |
| AKTX | Akari Therapeutics plc ADS | $7.90 | -7.49% | $18.1M |
| DARE | Dare Bioscience Inc. | $0.7477 | -0.32% | $14.7M |
| NEUP | Neuphoria Therapeutics Inc. | $3.39 | +2.11% | $18.3M |
| PTN | Palatin Technologies Inc. | $8.19 | -4.21% | $14.6M |
| RKTO | Rocket One Inc. | $0.5708 | -4.85% | $14.2M |
| KTTA | Pasithea Therapeutics Corp. | $0.4238 | -5.30% | $14.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier